SATRIC Drug Patent Profile
Which patents cover Satric, and when can generic versions of Satric launch?
Satric is a drug marketed by Savage Labs and is included in two NDAs.
The generic ingredient in SATRIC is metronidazole. There is one drug master file entry for this compound. Sixty-six suppliers are listed for this compound. Additional details are available on the metronidazole profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Satric
A generic version of SATRIC was approved as metronidazole by TEVA PHARMS USA on November 6th, 1984.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for SATRIC?
- What are the global sales for SATRIC?
- What is Average Wholesale Price for SATRIC?
Summary for SATRIC
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 136 |
| Clinical Trials: | 1 |
| Patent Applications: | 4,017 |
| DailyMed Link: | SATRIC at DailyMed |
Recent Clinical Trials for SATRIC
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Thomas Jefferson University | Early Phase 1 |
| Sidney Kimmel Cancer Center at Thomas Jefferson University | Early Phase 1 |
US Patents and Regulatory Information for SATRIC
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Savage Labs | SATRIC | metronidazole | TABLET;ORAL | 070029-001 | Mar 19, 1985 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Savage Labs | SATRIC | metronidazole | TABLET;ORAL | 070731-001 | Jun 8, 1987 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
